Companies · COAG · Biological Products, (No Diagnostic Substances)

Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings, Inc. (COAG) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Sep 24, 2026New audit director

Hemab adds Keli Walbert to board and audit committee without advancing pipeline

Clinical milestones advance, but quarterly loss modestly misses consensus

Related companies in Biological Products, (No Diagnostic Substances)

RXRX BCRX KYMR RVMD EXEL PCVX TWST IMCR GLUE IOVA TARS RGNX

Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact